IP Library › Granted Patent US 10,774,164
Granted Patent B2
US 10,774,164 · App. 16/544,567 · Granted Sep 15, 2020

Polymeric composition exhibiting nanogradient of refractive index

Inventors: Alexei V. Ossipov (Monrovia, CA); Keith Holliday (Lake Forest, CA)
Assignee: STAAR Surgical Company
C08F220/28A61L27/24A61L27/48A61L27/50C08L33/14G02B1/041A61F2/1627A61F2/1645A61F2002/1689A61F2210/0061A61F2250/0014A61L2400/12B29D11/00355C08F220/281C08L2203/02G02C7/022G02C2202/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,774,164
App. No.
16/544,567
Granted
Sep 15, 2020
Kind
B2
Abstract

Ionized radiation-absorbed, dose sensitive, highly flexible polymeric compositions are provided that exhibits multidirectional changes in refractive index. Also provided are methods of producing a precision multi-directional nanogradient of refractive index in a polymeric composition.

Claims (22)

1. An intraocular lens (IOL), comprising:

an optic body made from a three-dimensional polymeric matrix comprising a copolymer system comprising at least one non-ionic acrylic monomer,

wherein the three-dimensional polymeric matrix has a non-uniform cross-link density, wherein the non-uniform crosslink density of the matrix is adapted to create an anti-reflection surface layer in the optic body when the optic body is exposed to aqueous humor in an eye,

wherein the anti-reflection surface layer comprises a region of the matrix that is 50 nm to 100 microns thick,

wherein the anti-reflection surface layer is at least partially disposed around a central aperture formed in the optic body,

wherein said anti-reflection surface layer has been formed by irradiating the three-dimensional polymeric matrix with ionizing energy in a pattern configured to create said non-uniform cross-link density within the matrix.

2. The lens of claim 1 , wherein the three-dimensional polymeric matrix that has a non-uniform cross-link density includes a first region with fewer cross links than a second region.

3. The lens of claim 2 , wherein the first region and the second region are within a gradient of cross-link density.

4. The lens of claim 2 , wherein the first region is in a first layer with a first cross-link density, and the second region is in a second layer with a second cross-link density.

5. The lens of claim 2 , wherein the anti-reflection surface layer comprises the first layer.

6. The lens of claim 1 , wherein the entire optic body does not have a gradient cross-link density.

7. The lens of claim 1 , wherein the copolymer system further comprises at least one ionic monomer.

8. The lens of claim 7 , wherein the weight ratio of a first one of the at least one non-ionic acrylic monomer to a first one of the at least one ionic monomer is 10:1 to 10,000:1, such as 50:1 to 200:1, such as 75:1 to 175:1, such as 75:1, 100:1, 125:1, 150:1, or 175:1.

9. The lens of claim 7 , wherein the at least one ionic monomer comprises hydroxyethylmethacrylate.

10. The lens of claim 1 , wherein the copolymer system further comprises a collagen material.

11. The lens of claim 1 , wherein the optic body is an optic body of a phakic IOL.

12. The lens of claim 1 , further comprising a hydrating solution to which the optic body is exposed, wherein the non-uniform cross-link density causes the three-dimensional polymeric matrix to swell in a non-uniform manner when hydrated in the solution, thereby creating a non-uniform refractive index within the optic body.

13. The lens of claim 12 , wherein the hydrating solution is a balanced salt solution.

14. The lens of claim 12 , wherein the hydrating solution includes constituent parts such that when the lens is exposed to aqueous humor in an eye, the amount of swelling in the three-dimensional polymeric matrix will not substantially change.

15. The lens of claim 12 , wherein the hydrating solution includes at least one of magnesium ions or calcium ions.

16. The lens of claim 12 , wherein the non-uniform refractive index includes first and second discrete layers having first and second refractive indices, respectively.

17. The lens of claim 12 , wherein the non-uniform cross-link density includes a gradient cross-link density.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2020
From: OSSIPOV, ALEXEI V.; HOLLIDAY, KEITH
To: STAAR SURGICAL COMPANY
Reel/Frame 052030/0574 →
Continuity (2)
Provisional Application 62765088 · Aug 17, 2018
Related Publication 20200071440A1 · Mar 5, 2020
Cited By (1)
US 12,295,829